Yesterday, ELN and WYE were massacred, by Wall Street standards, because of a drug that was being developed for Alzheimer’s disease and failed in phase II trials. The experimental drug was said to “only help half of patients and was linked with a brain-swelling side effect” by Bloomberg.com. (You can read more about it here: http://www.bloomberg.com/apps/news?pid=20601103&refer=news&sid=aseKG.hyyRkw) In the aftermath, ELN … Read More